SBS Transit Ltd
SGX:S61
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SBS Transit Ltd
SGX:S61
|
SG |
|
Celyad Oncology SA
F:1C0S
|
BE |
|
C
|
Comfort Systems USA Inc
F:9CF
|
US |
|
I
|
Ipsen SA
OTC:IPSEF
|
FR |
|
ASML Holding NV
OTC:ASMLF
|
NL |
|
M
|
Motorola Solutions Inc
DUS:MTLA
|
US |
|
P
|
Prudential Financial Inc
F:PLL
|
US |
Wall St Price Targets
S61 Price Targets Summary
SBS Transit Ltd
According to Wall Street analysts, the average 1-year price target for S61 is 4.76 SGD with a low forecast of 4.72 SGD and a high forecast of 4.9 SGD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is S61's stock price target?
Price Target
4.76
SGD
According to Wall Street analysts, the average 1-year price target for S61 is 4.76 SGD with a low forecast of 4.72 SGD and a high forecast of 4.9 SGD.
What is the Revenue forecast for SBS Transit Ltd?
Projected CAGR
-2%
Over the last 14 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 2 years is -2%.
What is the Gross Profit forecast for SBS Transit Ltd?
Projected CAGR
0%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 4 years is 0%.
What is the Operating Income forecast for SBS Transit Ltd?
Projected CAGR
59%
Over the last 14 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 1 year is 59%.
What is the Pre-Tax Income forecast for SBS Transit Ltd?
Projected CAGR
-12%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 4 years is -12%.
What is the Net Income forecast for SBS Transit Ltd?
Projected CAGR
-2%
Over the last 14 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 4 years is -2%.
